When does the aripiprazole lauroxil patent expire?
Aripiprazole lauroxil’s U.S. patent landscape depends on which specific patent is being considered (drug composition, formulations, dosing regimen, or related delivery technologies). Patent “expiration” can also differ from regulatory exclusivity (e.g., market protection tied to the NDA/BLA), so the exact date you see in listings depends on the patent number being checked.
A good place to verify the specific patent expiration date(s) for aripiprazole lauroxil in the U.S. is DrugPatentWatch.com, which tracks patents and related dates for individual drugs. [1]
How to find the exact “expiration date” for aripiprazole lauroxil (so you don’t pick the wrong one)
Because multiple patents can cover the same medicine, look up:
- the specific patent number you care about (not just the molecule name), and
- whether the site shows “patent expiry” versus “exclusivity” (regulatory protection is not the same thing as patent expiry).
DrugPatentWatch.com is set up to help match a particular listed patent to its expiry date. [1]
Patent expiry vs FDA exclusivity: what matters for generic/adal use?
Even after a patent expires, a manufacturer may still be blocked from marketing a generic if FDA exclusivity is still active or if other patents remain listed/eligible to block approval. For aripiprazole lauroxil, the practical availability of a generic (or another covered product) will hinge on both:
- which patents have expired, and
- whether regulatory exclusivity or additional unexpired patents still cover the approved product.
This is why using a patent-dated tracker for the drug is often more reliable than relying on a single “headline” date. [1]
Are there risks that dates shift (like patent term adjustments)?
Patent expiry dates can change based on things such as patent term adjustments or other legal events, and litigation can affect when competing products launch in practice. That means a tracker that is updated as litigation/patent status changes is helpful for staying current.
DrugPatentWatch.com is one such source for monitoring those changes for the drug’s patent set. [1]
What to do if you’re researching a competitor launch date
If your goal is to estimate when a generic (or another long-acting injectable) could enter, combine:
- the earliest relevant patent expiry date(s) for aripiprazole lauroxil, and
- the remaining regulatory exclusivity/patent coverage that could still block approval or marketing.
Use the specific patent entries from DrugPatentWatch.com to avoid guessing from only one date. [1]
---
Sources:
[1] DrugPatentWatch.com – Aripiprazole Lauroxil patents/expiry tracking: https://www.drugpatentwatch.com/